| Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. | |
| | |
MedLine Citation:
|
PMID: 8606274 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: This study sought to readdress the definition of uncomplicated myocardial infarction and to apply clinical criteria for early discharge of such patients in the thrombolytic era. BACKGROUND: Previous studies proposed early hospital discharge at day 7 to 10 after acute myocardial infarction. The potential for earlier discharge of patients with uncomplicated infarction after thrombolysis remains undemonstrated. METHODS: We defined "uncomplicated infarction" a priori as the absence of death, reinfarction, ischemia, stroke, shock, heart failure (Killip class > 1), bypass surgery, balloon pumping, emergency catheterization or cardioversion or defibrillation in the first 4 hospital days. We applied this definition to 41,021 patients in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) trial. We examined death at 30 days and 1 year and rates of in-hospital reinfarction, heart failure, recurrent ischemia, shock and stroke in the uncomplicated and complicated groups created by application of our definition. We also assessed lengths of hospital and cardiac care unit stay. RESULTS: Application of our clinical criteria yielded 23,497 (57.3%) patients in the uncomplicated group at day 4 with a very low risk of death and in-hospital complications: 30-day mortality 1%, reinfarction 1.7%, heart failure 2.6%, recurrent ischemia 6.7%, shock 0.4% and stroke 0.2%. One-year mortality was 3.6%. The median hospital stay was 9 days (7, 12 [25th, 75th percentiles, respectively]), and the median cardiac care unit stay 3 days (3, 5). CONCLUSIONS: Simple clinical characteristics can identify a very low risk post-myocardial infarction population by hospital day 4. Use of these criteria for early discharge planning could substantially reduce length of stay for patients with uncomplicated acute myocardial infarction. |
| | |
Authors:
|
L K Newby; R M Califf; A Guerci; W D Weaver; J Col; J H Horgan; D B Mark; A Stebbins; F Van de Werf; J M Gore; E J Topol |
Related Documents
:
|
11399244 - Influence of l-carnitine and its derivatives on myocardial metabolism and function in i... 9615804 - Cardiac malignant lymphoma: a case report. 12197604 - Oozing-type of left ventricular rupture treated under percutaneous cardiopulmonary supp... 15520304 - Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocard... 15833694 - Chronic mesenteric ischemia. 3566384 - Anterolateral thoracotomy as an alternative to repeat median sternotomy for replacement... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 27 ISSN: 0735-1097 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 1996 Mar |
Date Detail:
|
Created Date: 1996-05-22 Completed Date: 1996-05-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 625-32 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine (Cardiology), Duke University Medical Center, Durham, North Carolina 27710, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Female Fibrinolytic Agents / therapeutic use* Follow-Up Studies Humans Length of Stay Male Middle Aged Myocardial Infarction / complications, diagnosis*, drug therapy*, mortality Patient Discharge* Patient Selection* Prognosis Recurrence Severity of Illness Index Streptokinase / therapeutic use Tissue Plasminogen Activator / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Electrocardiographic measurement of infarct size after thrombolytic therapy.
Next Document: Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evalu...